Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• Option Care Health, Inc. has received a consensus recommendation of "Moderate Buy" from nine research firms, with an average price target of $35.75.
• JPMorgan Chase & Co. increased its holdings in Option Care Health by 29.6%, reflecting strong institutional interest; 98.05% of the stock is owned by institutional investors and hedge funds.
• In the latest earnings report, Option Care Health reported $0.41 EPS, exceeding analysts' expectations, with a revenue increase of 15.4% compared to the previous year.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $35.75.

OPCH has been the topic of a number of analyst reports. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th.

Option Care Health Price Performance

NASDAQ:OPCH traded up $0.30 during trading hours on Wednesday, reaching $28.20. 1,072,228 shares of the company were exchanged, compared to its average volume of 1,608,567. The business has a 50 day moving average of $30.64 and a 200 day moving average of $31.92. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The company has a market capitalization of $4.58 billion, a P/E ratio of 22.56, a P/E/G ratio of 1.76 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the firm posted $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. Research analysts forecast that Option Care Health will post 1.22 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. increased its position in Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after acquiring an additional 344,875 shares during the period. Pictet Asset Management Holding SA grew its stake in shares of Option Care Health by 12.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 32,885 shares of the company's stock worth $763,000 after purchasing an additional 3,738 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Option Care Health by 121.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 142,441 shares of the company's stock valued at $3,305,000 after purchasing an additional 78,240 shares during the period. Alliancebernstein L.P. raised its position in Option Care Health by 4.5% during the 4th quarter. Alliancebernstein L.P. now owns 586,699 shares of the company's stock worth $13,611,000 after purchasing an additional 25,054 shares during the last quarter. Finally, ExodusPoint Capital Management LP lifted its holdings in Option Care Health by 167.8% during the 4th quarter. ExodusPoint Capital Management LP now owns 54,810 shares of the company's stock worth $1,272,000 after buying an additional 34,340 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.